eXoZymes Inc
EXOZ
6 hedge funds and large institutions have $802K invested in eXoZymes Inc in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.26% less ownership
Funds ownership: 1.21% → 0.94% (-0.26%)
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less capital invested
Capital invested by funds: $1.62M → $802K (-$816K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$66.5K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$56.9K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$11.1K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$238 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$456K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$34.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$8.08K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.34K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $526K | -$1.34K | -90 | -0.2% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $215K | +$56.9K | +3,832 | +23% |
|
|
3
BlackRock
New York
| $46.8K | +$66.5K | +4,474 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $11.8K | +$11.1K | +744 | +191% |
|
|
5
UBS Group
Zurich,
Switzerland
| $1.7K | -$8.08K | -544 | -77% |
|
|
6
Bank of America
Charlotte,
North Carolina
| $324 | +$238 | +16 | +107% |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$456K | -27,652 | Closed |
|
|
8
BNP Paribas Financial Markets
Paris,
France
| – | -$34.9K | -2,113 | Closed |
|
EXOZ Hedge Fund Activity: Q1 2025 in Review
6 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in eXoZymes Inc (EXOZ) for Q1 2025, worth a combined $802K — down 50% from $1.62M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of EXOZ and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was BlackRock, opening a new position worth an estimated $66.5K. The largest seller was Citadel Advisors, exiting entirely with an estimated $456K sold.
- 6 institutional investors held eXoZymes Inc (EXOZ) as of Q1 2025, down from 7 in Q4 2024.
- Funds reported $802K of eXoZymes Inc stock for Q1 2025, down 50% quarter-over-quarter.
- 1 fund opened new eXoZymes Inc positions in Q1 2025 and 2 closed out, a net change of -1 holder.
- The largest eXoZymes Inc buyer in Q1 2025 was BlackRock, an estimated $66.5K added.
- The largest eXoZymes Inc seller in Q1 2025 was Citadel Advisors, an estimated $456K sold.
Based on aggregated 13F filings for Q1 2025.